Omalizumab biosimilar (BiosanaPharma)
奥马珠单抗生物类似药（BiosanaPharma）
Report date: 2025/04/29 15:22:39
Base Information
Drug NameOmalizumab biosimilar (BiosanaPharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesBiosanaPharma BV
China Registration ClassN/A
Develop Information
Active CompaniesAdvanz Pharma CorpAlvotech Holdings SABiosanaPharma BV +[6]
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A